Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.91.63 CHF
Change Today -3.05 / -3.22%
Volume 310.0K
NOVNEE On Other Exchanges
Symbol
Exchange
Xetra
New York
OTC US
Mexico
SIX Swiss Ex
SIX Swiss Ex
Frankfurt
As of 11:09 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jonathan Richard Symonds CBE

AgeTotal Calculated CompensationThis person is connected to 59 board members in 5 different organizations across 11 different industries.

See Board Relationships
56--
As of Fiscal Year 2013

Background*

Mr. Jonathan Richard Symonds, also known as Jon, C.B.E., serves as Senior Advisor at GHO Capital Partners LLP. Mr. Symonds has been the Chief Financial Officer at Novartis Institutes for BioMedical Research, Inc. since September 1, 2009. Mr. Symonds serves as Deputy Chief Financial Officer at Novartis Vaccines and Diagnostics, Inc. He served as the Chief Financial Officer of Novartis AG from 2010 to May 1, 2013. Mr. Symonds served as an Advisor of Novartis AG since May ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

Director
2014-Present
Independent Non-Executive Director, Chairman of Group Audit Committee and Member of Conduct & Values Committee
2014-Present
Chairman and Chairman of Chairman's Nominations & Remuneration Committee
2014-Present
Director

Education*

BA 1980
University of Hertfordshire

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVNEE:SW SFr.91.63 CHF -3.05

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-2ND LINE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.